These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2650422)

  • 1. The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders.
    Slavin S; Naparstek E; Aker M; Cividalli G; Engelhard D; Hardan Y; Bromiker R; Brautbar C; Weshler Z; Or R
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3053-4. PubMed ID: 2650422
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E; Or R; Naparstek E; Zeira E; Slavin S
    Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial pneumonitis in T cell-depleted bone marrow transplantation.
    Breuer R; Or R; Lijovetzky G; Naparstek E; Engelhard D; Lafair J; Weshler Z; Slavin S
    Bone Marrow Transplant; 1988 Nov; 3(6):625-30. PubMed ID: 2850831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseases.
    Engelhard D; Or R; Strauss N; Morag A; Aker M; Naparstek E; Breuer R; Ravid Z; Sarov I; Lijovetzky G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3101-2. PubMed ID: 2539689
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.
    Slavin S; Or R; Naparstek E; Cividalli G; Weshler Z; Weiss L; Mumcuoglu M; Engelhard D; Aker M; Pollack A
    Isr J Med Sci; 1986; 22(3-4):264-7. PubMed ID: 3528046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unrelated match bone marrow transplantation for severe aplastic anemia].
    Urase F; Ishikawa H; Kanbara M; Hazu S; Tsuji K; Ashida T; Tsubaki K; Horiuchi A
    Rinsho Ketsueki; 1993 Dec; 34(12):1584-6. PubMed ID: 8295334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation.
    Rigden JP; Cornetta K; Srour EF; Hanna M; Broun ER; Hromas R; Baute J; Hilton J; Cox E; Rubin L; Gonin R; Tricot G
    Bone Marrow Transplant; 1996 Nov; 18(5):913-9. PubMed ID: 8932845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.
    Maraninchi D; Mawas C; Stoppa AM; Gaspard MH; Marit G; Van Ekthoven A; Reiffers J; Olive D; Hirn M; Delaage M
    Bone Marrow Transplant; 1989 Mar; 4(2):147-50. PubMed ID: 2650783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major.
    Or R; Naparstek E; Aker M; Cividalli G; Engelhard D; Brautbar C; Weshler Z; Weiss L; Mumcuoglu M; Rachmilewitz EA
    Prog Clin Biol Res; 1989; 309():217-22. PubMed ID: 2675089
    [No Abstract]   [Full Text] [Related]  

  • 14. Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graft.
    Miralbell R; Chapuis B; Nouet P; Helg C; Delorme H; Wacker P; Wyss M; Kurtz J
    Bone Marrow Transplant; 1993 Jun; 11(6):447-51. PubMed ID: 8334425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for severe aplastic anemia in Japan.
    Kanamaru A; Nagai K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():495-500. PubMed ID: 6394812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.
    Small TN; Avigan D; Dupont B; Smith K; Black P; Heller G; Polyak T; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):65-75. PubMed ID: 9267666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Booster irradiation to the spleen following total body irradiation. A new immunosuppressive approach for allogeneic bone marrow transplantation.
    Lapidot T; Singer TS; Salomon O; Terenzi A; Schwartz E; Reisner Y
    J Immunol; 1988 Oct; 141(8):2619-24. PubMed ID: 3049814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
    Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.